Becton, Dickinson and Company

BDX
HealthcareDividend King
$150.56
2.49%Undervalued

Becton, Dickinson and Company (BDX) is a Healthcare company that currently yields 2.49% — historically undervalued based on 10 years of dividend yield history. The Weiss valuation model places the undervaluation threshold at $179.98 and the overvaluation threshold at $278.10. Becton, Dickinson and Company holds a quality score of 70/100 (Good), reflecting 54 consecutive years of dividend growth with a 73% payout ratio. The 5-year dividend CAGR stands at 6.0%.

BDX Dividend Yield History — Weiss Valuation

Underval. $179.98Overval. $278.10

Distance to undervalued

In undervalued territory

Price sits 16.3% below the Weiss buy zone ceiling

The current yield already clears the historical undervaluation threshold. The next question is whether the dividend quality and payout profile deserve that higher yield.

Zone ceiling

$179.98

Current yield

2.49%

Research checklist

What to clear before buying the yield

Updated Jul 9, 2026

Dividend durability

54Y

Long dividend history supports a deeper look.

Earnings payout

73%

Earnings coverage leaves room for noise.

Cash payout

26%

Free cash flow coverage supports the payment.

Dividend growth

6.0%

Recent growth adds income compounding potential.

What changed

What changed since the last update

2026-07-082026-07-09

Price

-3.7%

$156.30 $150.56

Price fell 3.7% since the prior snapshot.

Why Now?

Becton, Dickinson and Company is trading near its historical undervaluation band.

Current yield 2.5% vs historical max 2.6% (95% of maximum).

14 consecutive years without a dividend cut.

Reasonable payout ratio of 73%.

What matters now

Read the signal before the headline yield

Valuation is the invitation here: the yield is elevated versus its own history.

The 70/100 quality score calls for selective follow-up, not autopilot.

Start by checking whether payout coverage and business durability still support the dividend.

BDX Dividend Income Projection — DRIP Compounder

Dividend Compounder (DRIP)

$

Year 1 Income

$264

Year 10 Income

$600

Yield on Cost

6.26%

Total Income

$4,068

Assumes dividends reinvested at current price. Simplified model — for illustrative purposes only.

Track actual vs. projected

See what BDX dividends you actually received with Sharesight

Dividend income log · Yield on cost · DRIP cost basis · Tax reports

More research

Full price history & technical analysis

TradingView ↗

Fundamentals, valuation & analyst ratings

FinViz ↗

Moat rating & analyst fair value

Morningstar ↗

Track dividends received & tax reports

Sharesight ↗

BDX Dividend Quality Score

Quality Score

70/ 100

Good

Payout Ratio5/25
Dividend Streak20/25
Growth (CAGR 5Y)15/20
Yield vs History15/15
FCF Coverage15/15

Key Metrics

Current Price$150.56
Annual Dividend$3.74
Current Yield2.49%
Yield — Max (10Y)2.61%
Yield — Min (10Y)1.37%
Undervalued Below$179.98
Overvalued Above$278.10
Payout Ratio72.95%
CAGR Dividend 5Y6.0%
CAGR Dividend 10Y5.7%
Years No Cut14y
In the buy zone

BDX is historically undervalued. Ready to add it to your portfolio?

Start investing on eToro →
No commission€50 minimumCopy trading

DividendVisual may earn a commission if you open an account via this link, at no cost to you. Capital at risk. Not financial advice.

54
consecutive years of dividend growth